- BSNL differs with Pitroda panel suggestions 1 comment(s)
- Industry Veterans Join Appian Board of Directors 0 comment(s)
- Nokia selects nine mobile application developers from Asia, Europe and the Americas to join 2008 Forum Nokia Innovation Series program 0 comment(s)
- BJL Dental Clinic | Affordable High Quality Dental Care and professional dental services to patients | Dental Tourism 0 comment(s)
- Precious yet irreverent, stylish and graceful – Timepieces from Diesel’s FW09 0 comment(s)
- Goldman picks up 73% in Century's 7-star hotel 0 comment(s)
- Women power behind Coorg coffee exotica 0 comment(s)
- Home Center by Lifestyle wins ‘Most Admired Retailer – Home and Office Improvement’ 0 comment(s)
- JSW seeks alliances for cement, aluminium biz 0 comment(s)
- Dorr-Oliver eyes Dahej for new plant 0 comment(s)
Market News
Information Technology
Telecom News
Industry News
General News
Commodities News
-
Pharma companies struggle to solve EU’s Rubik’s Cube
January 5, 2010 07:42:05Despite its potential for generic drugs, the European Union (EU) appears more like Hungarian sculptor Erno Rubik's 3-D Cube than a level playing field.Often seen in the same light as the US with respect to growth prospects for off-patent drugs (generics), vastly different situations in the 27 countries that make up the EU have made the bloc a tough market to tap for Indian drugmakers.Experts say the differences range from pricing pressures to segmentation, to prescription patterns a... Be First to give comment
Related Posts
- Pharma looks up to fresh opportunities in generics market
- Pharma drools at US patent expiries
- Painkiller biz grows @20%, pharma industry @14%
- Power T & D companies step up local focus
- Slim success for pharma firms in obesity drugs
Leave a Reply